Reply: Comment on The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences

Affiliations

¹ Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² Center for Clinical Trials, National Cancer Center, Goyang, Korea.
³ Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea. hyesukhan@chungbuk.ac.kr.

Comment

In-Ho Kim et al. J Gastric Cancer. 2024 Oct.

. 2024 Oct;24(4):353-355.

doi: 10.5230/jgc.2024.24.e40.

¹ Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² Center for Clinical Trials, National Cancer Center, Goyang, Korea.
³ Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea. hyesukhan@chungbuk.ac.kr.

No abstract available

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences.
Song GJ, Choi YY. Song GJ, et al. J Gastric Cancer. 2024 Jul;24(3):243-245. doi: 10.5230/jgc.2024.24.e26. J Gastric Cancer. 2024. PMID: 38960883 Free PMC article. No abstract available.

1. Song GJ, Choi YY. The necessity of guidance: optimizing adjuvant therapy for stage II/III MSI-H gastric cancer through the interplay of evidence, clinical judgment, and patient preferences. J Gastric Cancer. 2024;24:243–245. - PMC - PubMed
1. Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer. 2023;23:3–106. - PMC - PubMed
1. National Comprehensive Cancer Network (NCCN) National Comprehensive Cancer Network Guidelines in Oncology. Gastric Cancer. Version 4.2024 [Internet] Plymouth Meeting (PA): NCCN; 2024. [cited 2024 Sep 11]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.
1. European Society of Medical Oncology (ESMO) ESMO Gastric Cancer Living Guideline, v1.3 June 2024 [Internet] Lugano: ESMO; 2024. [cited 2024 Sep 11]. Available from: https://www.esmo.org/living-guidelines/esmo-gastric-cancer-living-guideline.
1. Wang FH, Zhang XT, Tang L, Wu Q, Cai MY, Li YF, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond) 2024;44:127–172. - PMC - PubMed